Liposarcoma future or investigational therapies: Difference between revisions
No edit summary |
|||
| Line 19: | Line 19: | ||
*Phase 4 trail | *Phase 4 trail | ||
It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease. | It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease. | ||
===SARC trials<ref name=SARC>{{cite web | title = SARC trials | url = http://www.sarctrials.org/sarc-clinical-trials }}</ref>=== | |||
==References== | ==References== | ||
Revision as of 05:38, 22 September 2014
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Liposarcoma future or investigational therapies |
|
Risk calculators and risk factors for Liposarcoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Clinical trials
Tests and treatment go through four different phases of clinical trail to test the benefits of it. The four phases of treatment are as follows.[1]
- Phase 1 trial
It aims to find out the best dose of a new drug with the lowest side effects
- Phase 2 trial
Asses whether a drug works for a specific cancer or not
- Phase 3 trial
Compares a new drug to a standard treatment
- Phase 4 trail
It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease.